These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11258675)
1. Role of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis. Colman RW Biol Chem; 2001 Jan; 382(1):65-70. PubMed ID: 11258675 [TBL] [Abstract][Full Text] [Related]
2. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460 [TBL] [Abstract][Full Text] [Related]
3. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113 [TBL] [Abstract][Full Text] [Related]
4. Opposing effects of low and high molecular weight kininogens on cell adhesion. Asakura S; Yang W; Sottile J; Zhang Q; Jin Y; Ohkubo I; Sasaki M; Matsuda M; Hirata H; Mosher DF J Biochem; 1998 Sep; 124(3):473-84. PubMed ID: 9722655 [TBL] [Abstract][Full Text] [Related]
5. The contact system and angiogenesis: potential for therapeutic control of malignancy. Colman RW Semin Thromb Hemost; 2004 Feb; 30(1):45-61. PubMed ID: 15034797 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic effect of cleaved high molecular weight kininogen is regulated by extracellular matrix proteins. Guo YL; Wang S; Cao DJ; Colman RW J Cell Biochem; 2003 Jun; 89(3):622-32. PubMed ID: 12761895 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of vitronectin-mediated haptotaxis and haptoinvasion of MG-63 cells by domain 5 (D5(H)) of human high-molecular-weight kininogen and identification of a minimal amino acid sequence. Kamiyama F; Maeda T; Yamane T; Li YH; Ogukubo O; Otsuka T; Ueyama H; Takahashi S; Ohkubo I; Matsui N Biochem Biophys Res Commun; 2001 Nov; 288(4):975-80. PubMed ID: 11689005 [TBL] [Abstract][Full Text] [Related]
8. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications]. Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906 [TBL] [Abstract][Full Text] [Related]
9. High molecular weight kininogen binds to laminin--characterization and kinetic analysis. Schousboe I; Nystrøm B FEBS J; 2009 Sep; 276(18):5228-38. PubMed ID: 19691495 [TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Cao DJ; Guo YL; Colman RW Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324 [TBL] [Abstract][Full Text] [Related]
12. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain. Page JD; You JL; Harris RB; Colman RW Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388 [TBL] [Abstract][Full Text] [Related]
13. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Chavakis T; Kanse SM; May AE; Preissner KT Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845 [TBL] [Abstract][Full Text] [Related]
14. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin. Etscheid M; Beer N; Fink E; Seitz R; Johannes D Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties. Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893 [TBL] [Abstract][Full Text] [Related]
16. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Meloni FJ; Gustafson EJ; Schmaier AH Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948 [TBL] [Abstract][Full Text] [Related]
17. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). Wachtfogel YT; DeLa Cadena RA; Kunapuli SP; Rick L; Miller M; Schultze RL; Altieri DC; Edgington TS; Colman RW J Biol Chem; 1994 Jul; 269(30):19307-12. PubMed ID: 8034694 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the coagulant activity and surface binding of high molecular weight kininogen. Colman RW; Silver LD; Purdon AD; Chang JJ; Scott CF Trans Assoc Am Physicians; 1984; 97():113-23. PubMed ID: 6336014 [TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. Lin Y; Pixley RA; Colman RW Biochemistry; 2000 May; 39(17):5104-10. PubMed ID: 10819977 [TBL] [Abstract][Full Text] [Related]